A detailed history of Envestnet Asset Management Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 11,761 shares of CTLT stock, worth $693,899. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,761
Previous 37,619 68.74%
Holding current value
$693,899
Previous $2.12 Million 66.34%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$56.16 - $60.96 $1.45 Million - $1.58 Million
-25,858 Reduced 68.74%
11,761 $712,000
Q2 2024

Aug 08, 2024

SELL
$53.58 - $57.02 $2.39 Million - $2.54 Million
-44,549 Reduced 54.22%
37,619 $2.12 Million
Q1 2024

May 13, 2024

SELL
$42.56 - $59.82 $12.5 Million - $17.5 Million
-293,184 Reduced 78.11%
82,168 $4.64 Million
Q4 2023

Feb 13, 2024

SELL
$32.18 - $46.57 $863,067 - $1.25 Million
-26,820 Reduced 6.67%
375,352 $16.9 Million
Q3 2023

Nov 13, 2023

BUY
$44.2 - $50.2 $5.72 Million - $6.5 Million
129,385 Added 47.43%
402,172 $18.3 Million
Q2 2023

Aug 04, 2023

SELL
$31.86 - $67.26 $3.06 Million - $6.46 Million
-95,985 Reduced 26.03%
272,787 $11.8 Million
Q1 2023

May 11, 2023

BUY
$45.44 - $74.26 $6.11 Million - $9.98 Million
134,447 Added 57.38%
368,772 $24.2 Million
Q4 2022

Feb 07, 2023

SELL
$41.39 - $81.0 $226,030 - $442,341
-5,461 Reduced 2.28%
234,325 $10.5 Million
Q3 2022

Nov 10, 2022

SELL
$72.36 - $113.1 $991,983 - $1.55 Million
-13,709 Reduced 5.41%
239,786 $17.4 Million
Q2 2022

Aug 03, 2022

BUY
$87.2 - $114.05 $4.63 Million - $6.05 Million
53,067 Added 26.48%
253,495 $27.2 Million
Q1 2022

May 04, 2022

BUY
$94.19 - $124.49 $1.4 Million - $1.85 Million
14,859 Added 8.01%
200,428 $22.2 Million
Q4 2021

Feb 04, 2022

BUY
$119.57 - $139.07 $756,878 - $880,313
6,330 Added 3.53%
185,569 $23.8 Million
Q3 2021

Oct 07, 2021

BUY
$109.17 - $142.35 $1.8 Million - $2.35 Million
16,495 Added 10.14%
179,239 $23.9 Million
Q2 2021

Aug 04, 2021

BUY
$100.34 - $115.69 $171,481 - $197,714
1,709 Added 1.06%
162,744 $17.6 Million
Q1 2021

May 04, 2021

BUY
$101.51 - $125.27 $1.55 Million - $1.91 Million
15,261 Added 10.47%
161,035 $17 Million
Q4 2020

Feb 02, 2021

BUY
$85.88 - $105.36 $39,848 - $48,887
464 Added 0.32%
145,774 $15.2 Million
Q3 2020

Oct 09, 2020

SELL
$72.74 - $92.5 $467,209 - $594,127
-6,423 Reduced 4.23%
145,310 $12.4 Million
Q2 2020

Jul 08, 2020

SELL
$48.02 - $79.04 $14,982 - $24,660
-312 Reduced 0.21%
151,733 $11.1 Million
Q1 2020

Apr 23, 2020

BUY
$36.95 - $62.95 $740,034 - $1.26 Million
20,028 Added 15.17%
152,045 $7.9 Million
Q4 2019

Feb 11, 2020

BUY
$47.06 - $56.64 $388,245 - $467,280
8,250 Added 6.67%
132,017 $7.43 Million
Q3 2019

Oct 17, 2019

BUY
$47.45 - $58.05 $828,714 - $1.01 Million
17,465 Added 16.43%
123,767 $5.9 Million
Q2 2019

Aug 02, 2019

BUY
$39.26 - $54.21 $189,900 - $262,213
4,837 Added 4.77%
106,302 $5.76 Million
Q1 2019

May 10, 2019

BUY
$29.84 - $43.92 $457,775 - $673,776
15,341 Added 17.81%
101,465 $4.12 Million
Q4 2018

Feb 13, 2019

BUY
$29.95 - $46.34 $2.58 Million - $3.99 Million
86,124 New
86,124 $2.69 Million
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $366,135 - $415,689
-9,126 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$38.72 - $42.52 $42,204 - $46,346
1,090 Added 13.56%
9,126 $382,000
Q1 2018

May 09, 2018

SELL
$39.4 - $47.39 $843,278 - $1.01 Million
-21,403 Reduced 72.7%
8,036 $330,000
Q4 2017

Feb 20, 2018

BUY
$37.27 - $43.02 $53,296 - $61,518
1,430 Added 5.11%
29,439 $1.21 Million
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $15,457 - $19,084
458 Added 1.66%
28,009 $1.12 Million
Q2 2017

Aug 14, 2017

BUY
N/A
27,551
27,551 $966,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.